CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Potential Hypertension Treatment Poised to Provide Reprieve to Millions of Patients

Nov 18, 2022

Lexaria Bioscience Corp. (NASDAQ: LEXX) is developing a potential hypertension treatment with little to no side effects. “The treatment is created by processing cannabidiol (‘CBD’) using the company’s patented DehydraTECH(TM) drug delivery technology, which has been shown to substantially increase the bioavailability of active pharmaceutical ingredients (‘APIs’). In human studies, Lexaria has shown that DehydraTECH-CBD not only increases the amount of CBD in the blood by as much as 317% but also reduces blood pressure and arterial stiffness,” a recent article reads. “Lexaria hopes to prove, through registered clinical trials, that its DehydraTECH-CBD formulation has an acceptable safety and tolerability profile and that it is effective against hypertension. The proof could potentially influence the registration of DehydraTECH-CBD as the second FDA-approved CBD drug, offering a reprieve to millions of hypertension patients who do not have their condition under control because they receive numerous antihypertensive drugs or are unwilling to suffer through these medications’ adverse side effects.”

To view the full article, visit https://cnw.fm/NfZQd

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids, antiviral drugs, PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 27 patents granted and roughly 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is part of the InvestorBrandNetwork.

More News

Watch: OpenAI’s Top Executives Talk Rogue Agents and A.I. Security
Nov 19, 2026
Watch: OpenAI’s Top Executives Talk Rogue Agents and A.I. Security

In an interview at the DealBook Summit, the co-founders Sam Altman and Greg Brockman discussed how to strike a balance between safety and risk.

Increase in direct cremations since pandemic
Nov 19, 2026
Increase in direct cremations since pandemic

A 2026 Cost of Dying Report found direct cremation was now chosen for around one in five funerals.

Gilts v kilts: What is happening with Scottish government bonds?
Nov 19, 2026
Gilts v kilts: What is happening with Scottish government bonds?

MSPs have heard both the pros and cons of the government's plan to launch its first ever bond to the market.

Leftover pumpkins help deliver 1,000th free meal
Nov 19, 2026
Leftover pumpkins help deliver 1,000th free meal

"It's a really tough time for a lot of people," a sustainable food organisation says.

What Nvidia’s Interim CEO, Colette Kress, Said to Employees After Jensen Huang’s Resignation
Nov 19, 2026
What Nvidia’s Interim CEO, Colette Kress, Said to Employees After Jensen Huang’s Resignation

At an all-hands meeting with employees, Colette Kress sought to put the indiscretions of Nvidia’s co-founder, Jensen Huang, behind them.

Have High Gas Prices Made You Change How You Drive? Tell Us About It.
Nov 19, 2026
Have High Gas Prices Made You Change How You Drive? Tell Us About It.

Are you driving less? Car pooling? Using a different vehicle? Tell us how the 2026 energy shock has affected you.

How Nvidia Chips Ended Up Within Reach of China’s Military
Nov 19, 2026
How Nvidia Chips Ended Up Within Reach of China’s Military

Alibaba, the Chinese internet giant behind the company at the center of the Nvidia spy saga, has used its A.I. computing technology to aid a lab with links to China’s military.

Takeaways From the 2026 DealBook Summit
Nov 19, 2026
Takeaways From the 2026 DealBook Summit

Leaders in artificial intelligence and governments discussed America’s shifting politics, the reverberations of Jensen Huang’s ouster at Nvidia and more on Wednesday.

Elon Musk says record $446m spending on US midterms was 'pretty foolish'
Nov 19, 2026
Elon Musk says record $446m spending on US midterms was 'pretty foolish'

The multi-billionaire also said he was "not Maga", distancing himself from the political movement linked to Trump.

Anthropic’s Public Debut Sets Up ‘Experiment’ in Corporate Power
Nov 19, 2026
Anthropic’s Public Debut Sets Up ‘Experiment’ in Corporate Power

The artificial intelligence giant will become by far the largest publicly traded “public benefit corporation,” a structure that mandates it balance safety and profit.

Watch: Robinhood’s C.E.O. Says He Shouldn’t Decide What You Can Trade
Nov 19, 2026
Watch: Robinhood’s C.E.O. Says He Shouldn’t Decide What You Can Trade

Speaking alongside the Nasdaq chief Adena Friedman and the Polymarket founder Shayne Coplan, Vlad Tenev said regular investors should have access to more opportunities.

Graphics: The numbers behind China-US bilateral trade
Nov 19, 2026
Graphics: The numbers behind China-US bilateral trade

Graphics: The numbers behind China-US bilateral trade

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Marketers Log

Marketers Log is your personal Business & Finance news site to provide marketing or market-related news.

Newsletter